share_log

西藏药业(600211.SH)获产业扶持资金5303.05万元

Tibet Pharmaceutical (600211.SH) received 53.035 million yuan in industrial support capital

Zhitong Finance ·  Dec 14, 2023 02:52

Tibet Pharmaceutical (600211.SH) announced that the company and its subsidiary Tibet Nordicang Pharmaceutical Co., Ltd. in 2023...

According to the Zhitong Finance App, Tibet Pharmaceutical (600211.SH) announced that the company and its subsidiary Tibet Nodicon Pharmaceutical Co., Ltd. received 53.035 million yuan in industrial support funds from the Shannan Happy Home Construction Administration on December 14, 2023, accounting for 14.34% of the company's net profit attributable to shareholders of listed companies in the most recent period (2022).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment